Additional file 4: of Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Table S1. Patient characteristics and list of PBMC samples selected for the current analysis from the POPLAR trial. (XLSX 11 kb)
创建时间：
2019-09-12
